SUBSCRIBE
SUBSCRIBE

Phase 2

Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Comeback Kid Exelixis Could Pose a Huge Threat to Biotech Giants Bristol-Myers Squibb and Pfizer
October 17, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
A Look at CRISPR, ‘Biotech’s Biggest Discovery of the Century,’ and the 3 Companies Knee Deep in It
October 17, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
FDA Slaps Hold on Regeneron, Teva’s Pain Drug Fasinumab
October 17, 2016
 · 
2 min read
ESMO 2016 Takeaways: Don't Miss Celldex, Exelixis and Tesaro
Drug Development
ESMO 2016 Takeaways: Don’t Miss Celldex, Exelixis and Tesaro
October 12, 2016
 · 
3 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
Synairgen Stock Tanks After Partner AstraZeneca PLC Halts Asthma Drug Trial
October 12, 2016
 · 
3 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
3 Biotechs With Cancer Drugs That Could Win Approval in 2017
October 10, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Bay Area Exelixis’ Cabometyx Beats the Pants Off Pfizer’s Sutent in Mid-Stage Kidney Cancer Study
October 10, 2016
 · 
2 min read
Bristol-Myers Squibb Looks Over Its Shoulder as Opdivo Disappoints While Merck & Co.'s Keytruda Shines in Lung Cancer Study
Drug Development
Bristol-Myers Squibb Looks Over Its Shoulder as Opdivo Disappoints While Merck & Co.'s Keytruda Shines in Lung Cancer Study
October 10, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Drug Development
Clovis Oncology Stock Hammered After Revealing Mixed Results for Rucaparib
October 7, 2016
 · 
2 min read
Drug Development
Why SCYNEXIS, Inc. Is Making A Run
October 7, 2016
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study
May 7, 2026
 · 
5 min read
Press Releases
Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study
May 7, 2026
 · 
15 min read
Press Releases
PHERGain and PHERGain-2 advance therapeutic de-escalation in early HER2-positive breast cancer in selected patients
May 7, 2026
 · 
5 min read
Press Releases
Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
 · 
18 min read
Press Releases
Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer
May 7, 2026
 · 
7 min read
Press Releases
Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026
May 7, 2026
 · 
1 min read
Press Releases
Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101
May 6, 2026
 · 
5 min read
Press Releases
Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
May 6, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 6, 2026
 · 
14 min read
Press Releases
InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases
May 6, 2026
 · 
10 min read
Press Releases
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response
May 6, 2026
 · 
12 min read
Press Releases
Eupraxia Pharmaceuticals’ First Release of EoEHSS Sub Scores Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week
May 6, 2026
 · 
11 min read
Press Releases
Immunocore reports first quarter 2026 financial results and provides a business update
May 6, 2026
 · 
22 min read
Press Releases
Spago Nanomedical’s Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake
May 6, 2026
 · 
3 min read
Press Releases
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of Intermediate Age-Related Macular Degeneration (AMD) at Association for Research in Vision and Ophthalmology (ARVO) 2026
May 6, 2026
 · 
2 min read
Press Releases
Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results
May 6, 2026
 · 
14 min read
Press Releases
Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients
May 6, 2026
 · 
5 min read
Press Releases
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results
May 6, 2026
 · 
15 min read
Press Releases
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa
May 6, 2026
 · 
10 min read
Press Releases
Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting
May 6, 2026
 · 
6 min read
Load More